Regenerex Pharma Income Statement (2010-2025) | RGPX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Sep2020	Dec2020	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025
Revenue & cost
Revenue (Quarter)	120.00	181.00
Cost of Revenue (Quarter)	234.00	364.00	0.00M	218.00	612.00				300.00		0.00M
Gross Profit (Quarter)	86.00	-183.00
Operating items
Research & Development (Quarter)												2.40M					0.02M	0.65M		0.14M
Selling, General & Administrative (Quarter)	0.01M	0.01M	0.01M	0.02M	0.06M	0.03M	0.02M	0.02M	0.03M	0.03M	0.16M	0.39M	0.24M	-0.13M	0.25M	0.26M	0.29M	-0.18M	0.63M	0.65M
Restructuring Costs (Quarter)
Other Operating Expenses (Quarter)	234.00	0.00M												0.41M				0.54M
Operating Expenses (Quarter)	0.01M	0.01M	0.01M	0.02M	0.06M	0.03M	0.02M	0.02M	0.03M	0.03M	0.16M	2.79M	0.24M	0.28M	0.25M	0.26M	0.31M	1.00M	0.63M	0.79M
Operating Income (Quarter)	-0.01M	-0.01M	-0.01M	-0.02M	-0.06M	-0.03M	-0.02M	-0.02M	-0.03M	-0.03M	-0.16M	-2.79M	-0.24M	-0.28M	-0.25M	-0.26M	-0.31M	-1.00M	-0.63M	-0.79M
EBIT (Quarter)	-0.01M	-0.01M	-0.01M	-0.02M	-0.06M	-0.03M	-0.02M	-0.02M	-0.03M	-0.03M	-0.16M	-2.79M	-0.24M	-0.28M	-0.25M	-0.26M	-0.31M	-1.00M	-0.63M	-0.79M
Non-operating items
Other Non Operating Income (Quarter)	-0.00M	-0.01M	-0.00M	0.01M	-0.00M	-0.01M	0.01M	0.02M	-0.00M	-588.00	-0.01M	0.00M	-0.00M	0.01M	0.00M	-0.01M			-0.01M	-539.00
Non Operating Income (Quarter)	-0.01M	-0.02M	-0.02M	-0.01M	-0.02M	-0.02M	-0.01M	0.00M	-0.02M	-0.02M	-0.03M	-0.02M	-0.02M	-0.01M	-0.02M	-0.27M	-0.00M	-0.41M	-0.03M	-0.03M
Net income details
EBT (Quarter)	-0.02M	-0.03M	-0.02M	-0.04M	-0.08M	-0.05M	-0.03M	-0.04M	-0.05M	-0.09M	-0.18M	-2.81M	-0.26M	-0.36M	-0.28M	-0.52M	-0.34M	-1.31M	-0.66M	-0.79M
Tax Provisions (Quarter)																			-113.00	-50.00
Profit After Tax (Quarter)	-0.03M	-0.03M	-0.03M	-0.03M	-0.08M	-0.06M	-0.02M	-0.02M	-0.05M	-0.05M	-0.19M	-2.80M	-0.26M	-0.29M	-0.27M	-0.53M	-0.31M	-1.41M	-0.66M	-0.81M
Income from Continuing Operations (Quarter)	-0.02M	-0.03M	-0.02M	-0.04M	-0.08M	-0.05M	-0.03M	-0.04M	-0.05M	-0.09M	-0.18M	-2.81M	-0.26M	-0.36M	-0.28M	-0.52M	-0.34M	-1.31M	-0.66M	-0.79M
Consolidated Net Income (Quarter)	-0.02M	-0.03M	-0.02M	-0.04M	-0.08M	-0.05M	-0.03M	-0.04M	-0.05M	-0.09M	-0.18M	-2.81M	-0.26M	-0.36M	-0.28M	-0.52M	-0.34M	-1.31M	-0.66M	-0.79M
Income towards Parent Company (Quarter)	-0.02M	-0.03M	-0.02M	-0.04M	-0.08M	-0.05M	-0.03M	-0.04M	-0.05M	-0.09M	-0.18M	-2.81M	-0.26M	-0.36M	-0.28M	-0.52M	-0.34M	-1.31M	-0.66M	-0.79M
Net Income towards Common Stockholders (Quarter)	-0.02M	-0.03M	-0.02M	-0.04M	-0.08M	-0.05M	-0.03M	-0.04M	-0.05M	-0.09M	-0.18M	-2.81M	-0.26M	-0.36M	-0.28M	-0.52M	-0.34M	-1.31M	-0.66M	-0.79M
Additional items
EPS (Basic) (Quarter)	0.00	0.00	0.00	0.00	0.00	0.00	0.00			0.00	-0.16	-0.01	0.00	0.00	-0.10	-0.18	-0.11	-0.01	0.00	0.00
EPS (Weighted Average and Diluted) (Quarter)
Shares Outstanding (Weighted Average) (Quarter)	127.11M	127.11M	127.11M	127.11M	203.74M	183.41M	127.11M			277.11M	1.11M	2.31M	277.54M	277.65M	2.73M	2.91M	3.04M	278.73M	281.12M	281.41M
Shares Outstanding (Diluted Average) (Quarter)
EBITDA (Quarter)	-0.01M	-0.01M	-0.01M	-0.02M	-0.06M	-0.03M	-0.02M	-0.02M	-0.03M	-0.03M	-0.16M	-2.79M	-0.24M	-0.28M	-0.25M	-0.26M	-0.31M	-1.00M	-0.63M	-0.79M
Interest Expenses (Quarter)	0.01M	0.01M	0.01M	0.02M	0.01M	0.01M	0.02M	0.02M	0.02M	0.07M	0.02M	0.02M	0.02M	0.08M	0.02M	0.27M	0.03M	0.30M	0.02M	0.00M
Tax Rate (Quarter)																			0.02%	0.01%

Research Tools

Developers

Regenerex Pharma Income Statement (2010-2025) | RGPX

Research Tools

Developers

Regenerex Pharma Income Statement (2010-2025) | RGPX

Create an account

Sign In

Reset Password